ELAA Technology is a digital health company founded in 2017 with headquarters in the United Kingdom. The company's slogan, "a digital health company focusing on early diagnosis of lung, colorectal and prostate cancers," reflects its primary focus on cancer early diagnosis within the Health Care and Medical Devices industries. ELAA Technology has developed a patent-pending Pure Digital Medical Navigation Platform, serving as the foundation for its innovative products tailored for the cancer early diagnosis market. In addition to its core focus, the company has also expanded its portfolio to include titanium plate and screw systems catering to a wide range of surgeries, such as cardiovascular, thoracic, plastic, orthopedic, neuro, ENT, and maxillofacial surgeries. With an emphasis on technology and healthcare, ELAA Technology presents an interesting opportunity for investors looking to capitalize on advancements in early cancer detection and medical devices. Although specific details about the last investment and investors are not available, the company's multi-faceted approach to addressing critical medical needs positions it as a compelling player in the digital health and medical technology sectors.
There is no investment information
No recent news or press coverage available for ELAA Technology.